skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Metabolism of /sup 35/S- and /sup 14/C-labeled 1-methyl-2-mercaptoimidazole in vitro and in vivo

Journal Article · · Endocrinology; (United States)
OSTI ID:6568957

We previously described an in vitro incubation system for studying the mechanism of inhibition of thyroid peroxidase (TPO)-catalyzed iodination by the antithyroid drug 1-methyl-2-mercaptoimidazole (MMI). Inhibition of iodination in this system may be reversible or irreversible, depending on the relative concentrations of iodide and MMI and on the TPO concentration. Metabolism of the drug occurs under both conditions, and in the present investigation we used 35S- and 14C-labeled MMI together with reverse phase HPLC to examine the metabolic products associated with reversible and irreversible inhibition of iodination by MMI. Under conditions of reversible inhibition, MMI was rapidly metabolized and disappeared completely from the incubation mixture. With (35S)MMI, the earliest detectable 35S-labeled product was MMI disulfide, which reached a peak after a few minutes and then declined to undetectable levels. Coincident with the decrease in disulfide was the appearance of two 35S peaks, the major one corresponding to sulfate/sulfite, and the other to a component eluting at 7.5 min. Similar results were obtained for the disulfide and for the 7.5 min metabolite with (14C)MMI. The major 14C-labeled metabolite containing no S appeared to be 1-methylimidazole. Under conditions of irreversible inhibition, MMI disulfide was also the earliest detectable 35S-labeled metabolite. However, MMI decreased more slowly, and after reaching a nadir at about 6 min returned gradually to a level about halfway between the initial and the minimum value. The reformation of MMI appeared to involve the nonenzymatic disproportionation of MMI disulfide. Formation of the 7.5 min peak was also observed, but there was no formation of sulfate/sulfite.

Research Organization:
Univ. of Texas Southwestern Medical Center, Dallas (USA)
OSTI ID:
6568957
Journal Information:
Endocrinology; (United States), Vol. 124:1
Country of Publication:
United States
Language:
English

Similar Records

Metabolism of /sup 35/S- and /sup 14/C-labeled propylthiouracil in a model in vitro system containing thyroid peroxidase
Journal Article · Thu Jun 01 00:00:00 EDT 1989 · Endocrinology; (United States) · OSTI ID:6568957

Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil
Journal Article · Fri Jul 01 00:00:00 EDT 1983 · Endocrinology; (United States) · OSTI ID:6568957

Reexamination of the proposed inactivation of thyroid peroxidase in the rat thyroid by propylthiouracil
Journal Article · Thu Jun 01 00:00:00 EDT 1989 · Endocrinology; (United States) · OSTI ID:6568957